Riskpilot← Back to searchSign inGet full accessHEMAFA INVEST AS
ASActiveOrg 988405396Skøyenveien 15A, 0375 OsloWholesale of other food · NACE 4638Est. 20050 employees
Revenue 2025
NOK 334K
-12% vs 2024
EBITDA margin
10.4%
-85% vs 2024
Equity ratio
64.3%
Financial strength
Net profit 2025
NOK 3,4M
+25% vs 2024
| Revenue | NOK 334K | -12% |
| EBITDA | NOK 35K | -85% |
| Net profit | NOK 3,4M | +25% |
| Total assets | NOK 22,3M | +5% |
| Equity | NOK 14,4M | +18% |
| Employees | 0 | — |
Legal name
HEMAFA INVEST AS
Org number
988405396
Legal form
Aksjeselskap
NACE code
4638 · Wholesale of other food
Founded
1. september 2005
Share capital
NOK 102 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Handel med nærings- og nytelsesmidler, investering i aksjer og andeler, samt annen investering som kan sikre en fornuftig avkastning på selskapets midler.
Address
Skøyenveien 15A, 0375 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 305 | 380 | 334 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −37 | −124 | 50 | 225 | 35 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −37 | −124 | 50 | 225 | 35 |
| Net financials | 236 | 2 085 | 2 212 | 2 547 | 3 405 |
| Profit before tax | 199 | 1 961 | 2 262 | 2 771 | 3 440 |
| Tax | 1 | 3 | 27 | 22 | 14 |
| Net profit | 198 | 1 959 | 2 236 | 2 749 | 3 426 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 9 099 | 20 020 | 23 690 | 21 168 | 22 321 |
| Equity | 8 450 | 9 315 | 10 633 | 12 158 | 14 360 |
| Long-term debt | 0 | 9 777 | 12 128 | 8 081 | 7 031 |
| Short-term debt | 650 | 928 | 929 | 930 | 930 |
| Total debt | 650 | 10 704 | 13 057 | 9 010 | 7 961 |
EBITDA margin
10.4%
This company
15.8%
Market median
-34% vs market
20212025
Equity ratio
64.3%
This company
38.2%
Market median
+68% vs market
20212025
Return on equity
23.9%
This company
18.4%
Market median
+30% vs market
20212025
Net profit margin
1026.7%
This company
8.1%
Market median
+12575% vs market
20212025
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20212025
Debt / equity
0.55×
This company
0.62×
Market median
+11% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IT Deputy Member | Deputy Member | 2005 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 2.94% | 2.94% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HEMAFA INVEST AS (this company)
COSMO-TEX ASBoard members of HEMAFA INVEST AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ingrid Tøien Markussen | Deputy Member | 0 companies |